Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer

WALTHAM, Mass., Nov. 14, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, announced today that its Board of Directors has appointed Stephen P....
November 06, 2013 07:35 ET | Source: BG Medicine, Inc.

BG Medicine Reports 2013 Third Quarter Financial Results

Capital Health Accountable Care Organization LLC Adopts BGM Galectin-3® Test Network of Laboratories in U.S. Offering BGM Galectin-3Test Expanded Full-Year 2013 Product Revenue and Cash...
November 06, 2013 07:30 ET | Source: BG Medicine, Inc.

SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test

WALTHAM, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test and SilverStaff Clinical Laboratories, Inc. today announced that SilverStaff...
October 30, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013

WALTHAM, Mass., Oct. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, November 6 at 8:30 a.m. Eastern...
September 30, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test

WALTHAM, Mass., Sept. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that the Centers for Medicare and Medicaid Services (CMS) have made a preliminary decision to set the...
September 23, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients

WALTHAM, Mass., Sept. 23, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of the results of a clinical research study conducted at the Massachusetts General...
September 19, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the Heart Failure Society of America

WALTHAM, Mass., Sept. 19, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the...
September 04, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference

WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the...
August 08, 2013 07:45 ET | Source: BG Medicine, Inc.

BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook

Focusing Investments on Increasing U.S. and EU Galectin-3 Adoption 2013 Financial and Operational Guidance Provided WALTHAM, Mass., Aug. 8, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc....
August 01, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine to Announce Second Quarter 2013 Financial Results and Host Conference Call on Thursday, August 8, 2013

WALTHAM, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, August 8 at 8:30 a.m. Eastern...